LIAISON LymeDetect

Device DiaSorin Inc.
Total Payments
$1.0M
Transactions
8
Doctors
0
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $249,701 2 0
2023 $593,777 3 0
2022 $132,764 2 0
2021 $52,293 1 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $1.0M 8 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
LIAISON LymeDetect - (500685) DiaSorin Inc. $649,628 0
Quantiferon Lyme DiaSorin Inc. $152,850 0
LIAISON LymeDetect - PROT.648.00024 (500544) DiaSorin Inc. $147,533 0
LymeDetect (Project 500685) Clinical Study DiaSorin Inc. $41,000 0
LymeDetect Clinical Study DiaSorin Inc. $37,524 0

Top Doctors Receiving Payments for LIAISON LymeDetect

Doctor Specialty Location Total Records
Unknown La Crosse, WI $1.0M 8

About LIAISON LymeDetect

LIAISON LymeDetect is a device associated with $1.0M in payments to 0 healthcare providers, recorded across 8 transactions in the CMS Open Payments database. The primary manufacturer is DiaSorin Inc..

Payment data is available from 2021 to 2024. In 2024, $249,701 was paid across 2 transactions to 0 doctors.

The most common payment nature for LIAISON LymeDetect is "Unspecified" ($1.0M, 100.0% of total).

LIAISON LymeDetect is associated with 5 research studies, including "LIAISON LymeDetect - (500685)" ($649,628).